Viewing Study NCT01992159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT01992159
Status: COMPLETED
Last Update Posted: 2019-03-25
First Post: 2013-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postmenopausal Osteoporosis (PMO) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases View